Cytek Biosciences (CTKB) Interest & Investment Income (2020 - 2026)
Cytek Biosciences' (CTKB) quarterly Interest & Investment Income came in at $787000.0 in Q1 2026, up 54.92% YoY from $508000.0 in Q1 2025, and up 35.69% on a QoQ basis from $580000.0 in Q4 2025.
Cytek Biosciences (CTKB) Interest & Investment Income (2020 - 2026) Analysis & Trends
Cytek Biosciences (CTKB) has 7 years of Interest & Investment Income data on file, last reported at $787000.0 in Q1 2026.
- Quarterly Interest & Investment Income rose 54.92% year-over-year to $787000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (down 41.57% YoY) and the FY2025 annual result came in at $2.2 million, down 56.73% from the prior year.
- Interest & Investment Income improved to $787000.0 in Q1 2026, from $580000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $2.6 million in Q4 2022 to a low of $18000.0 in Q1 2022.
- A 5-year average of $1.1 million and a median of $1.2 million in 2023 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income jumped 14488.89% — and 2025, when it plunged 62.62%.
- Tracing CTKB's Interest & Investment Income over 5 years: stood at $2.6 million in 2022, then sank by 44.86% to $1.4 million in 2023, then slumped by 36.95% to $913000.0 in 2024, then tumbled by 36.47% to $580000.0 in 2025, then jumped by 35.69% to $787000.0 in 2026.
- The last three Interest & Investment Income figures came in at $787000.0 (Q1 2026), $580000.0 (Q4 2025), and $573000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn | 30.00 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn | 73.23 Mn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | - |
| 10 | Cytek Biosciences | 615.21 Mn | 541.36 Mn | 28.34 Mn | 819,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 819,000.00 |
| Mar 31, 2026 | 787,000.00 |
| Dec 31, 2025 | 580,000.00 |
| Sep 30, 2025 | 573,000.00 |
| Jun 30, 2025 | 555,000.00 |
| Mar 31, 2025 | 508,000.00 |
| Dec 31, 2024 | 913,000.00 |
| Sep 30, 2024 | 1.43 Mn |
| Jun 30, 2024 | 1.42 Mn |
| Mar 31, 2024 | 1.36 Mn |
| Dec 31, 2023 | 1.45 Mn |
| Sep 30, 2023 | 1.62 Mn |
| Jun 30, 2023 | 1.20 Mn |
| Mar 31, 2023 | 2.14 Mn |
| Dec 31, 2022 | 2.63 Mn |
| Sep 30, 2022 | 1.58 Mn |
| Jun 30, 2022 | 391,000.00 |
| Mar 31, 2022 | 18,000.00 |
| Dec 31, 2021 | 18,000.00 |
| Sep 30, 2021 | 12,000.00 |